Table 5:
Treatment outcomes descriptives by change in employment status.
| UU n = 169 (36.3%) |
EU n = 54 (11.6%) |
UE n = 121 (26%) |
EE n = 122 (26.2%) |
|
|---|---|---|---|---|
| Clinical outcomes within treatment | ||||
| Percentage of days abstinent during treatment (Mean ± SD) | 63 ± 29.6 | 68.4 ± 30.4 | 76.3 ± 24.3 | 72.7 ± 22.3 |
| Percentage cocaine-negative samples during treatment (Mean ± SD) | 21.3 ± 30.7 | 36.3 ± 38.6 | 38.2 ± 37.8 | 29.9 ± 36.3 |
| Achieved 3 or more weeks of consecutive cocaine abstinence (N (%)) | 48 (28.4) | 20 (37) | 56 (46.3) | 37 (30.3) |
| Longest duration abstinence during treatment (days) (Mean ± SD) | 14.6 ± 18.4 | 21.5 ± 23.5 | 27.1 ± 27.1 | 18.3 ± 21.1 |
| Retained and abstinence in last week of treatment (N (%)) | 37 (22.3) | 18 (37.5) | 42 (36.8) | 32 (26.7) |
| Complete abstinence during treatment (N (%)) | 7 (4.3) | 7 (13) | 14 (11.8) | 12 (10) |
| Clinical outcomes at follow-up | ||||
| Percentage of days abstinent at follow-up month 1 (Mean ± SD) | 75.2 ± 30.4 | 81.2 ± 27.6 | 83.1 ± 25.9 | 81.5 ± 23.7 |
| Employment at follow-up month 1 (N (%)) | 29 (18.8) | 14 (28.6) | 109 (91.6) | 115 (95) |
| Percentage of days abstinent at follow-up month 3 (Mean ± SD) | 79.2 ± 31.6 | 84 ± 25.3 | 85.3 ± 23.1 | 81.3 ± 26.1 |
| Employment at follow-up month 3 (N (%)) | 42 (27.6) | 19 (38.8) | 98 (84.5) | 109 (90.1) |
| Percentage of days abstinent at follow-up month 6 (Mean ± SD) | 80.2 ± 30.8 | 83.3 ± 26.4 | 83.5 ± 25.4 | 80.9 ± 27.6 |
| Employment at follow-up month 6 (N (%)) | 64 (41.6) | 26 (55.3) | 90 (83.3) | 98 (83.1) |
UU = unemployed at baseline and at the end-of-treatment; EU = employed at baseline and unemployed at the end-of-treatment;
UE = unemployed at baseline and employed the end-of-treatment; EE = and employed at baseline and at the end-of-treatment;
SE = Standard Error; OR = Odds Ratio.; ns = statistically non-significant.